Cost-effective control of drug-resistant TB: listening to other voices.
Portero
Jose Luis
JL
Rubio
Maria
M
D000995:Antitubercular Agents / Q000191:economics*; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003906:Developing Countries / Q000191:economics; D016527:Drug Costs; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000191:economics* / Q000517:prevention & control
D000995:Antitubercular Agents